ArticleCellular and molecular life sciences : CMLS2026
RBMX promotes colorectal liver metastasis by stabilizing MTHFD2 mRNA to regulate redox homeostasis.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundLiver metastasis is the primary cause of mortality in colorectal cancer (CRC), yet the molecular mechanisms driving colorectal liver metastasis (CRLM) remain poorly understood. This study investigates the role of RNA-binding motif protein X (RBMX) in CRLM progression and its underlying mechanisms.
methodsRBMX expression and clinical significance were analyzed in public databases (GEO, TCGA) and in-house cohorts. Metastatic function was assessed using in vitro and in vivo models. Mechanistically, RNA sequencing, RNA immunoprecipitation (RIP), and RNA pull-down assays were employed to identify downstream targets. Metabolic profiling, reactive oxygen species (ROS) quantification, and signaling pathway analyses were used to evaluate redox homeostasis.
resultsRBMX was upregulated in CRLM tissues and correlated with poor prognosis. It significantly promoted CRC cells migration, invasion, and liver metastasis. Mechanistically, RBMX directly bound to and stabilized MTHFD2 mRNA, increasing its protein abundance. This upregulation rewired one-carbon metabolism to boost NADPH production, effectively buffering intracellular ROS. Consequently, RBMX suppressed ROS-dependent p38/JNK stress signaling, sustaining metastatic cell survival.
conclusionsOur study reveals that RBMX drives CRLM by stabilizing MTHFD2 mRNA to maintain redox homeostasis. This "RBMX-MTHFD2-Redox" axis links RNA stability to metabolic plasticity, representing a novel mechanistic vulnerability in CRLM and promising candidate for preclinical therapeutic development and biomarker investigation.
Indexed as
Identifiers
42417838What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.